Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
azapirones
Description:
A class of psychoactive drugs used primarily for their anxiolytic effects and other psychiatric applications.
Primary topic:
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (24%)
Related topics:
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (24%),
Treatment of Major Depression (19%),
Neurotransmitter Receptor Influence on Behavior (16%)
Wikidata ID:
wiki/Q4352014
OpenAlex ID:
keywords/azapirones
Is there a role for 5-HT1A agonists in the treatment of depression?
2003
·
Pierre Blier
, Nick M Ward
·
Biological Psychiatry
·
588
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
2010
·
Lakshmi N. Ravindran
, Murray B. Stein
·
The Journal of Clinical Psychiatry
·
404
The elevated T-maze: A new animal model of anxiety and memory
1994
·
M.B. Viana
, C. Tomaz
, et al.
·
Pharmacology Biochemistry and Behavior
·
286
An effect-size analysis of pharmacologic treatments for generalized anxiety disorder
2007
·
Rosario B. Hidalgo
, Larry A. Tupler
, et al.
·
Journal of Psychopharmacology
·
198
Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety
1999
·
John J. Sramek
, Walter W. Hong
, et al.
·
Depression and Anxiety
·
185
PDF
Clinical Effects of the 5-HT1A Partial Agonists in Depression: A Composite Analysis of Buspirone in the Treatment of Depression
1990
·
DONALD S. ROBINSON
, KARL RICKELS
, et al.
·
Journal of Clinical Psychopharmacology
·
183
Azapirones for generalized anxiety disorder
2006
·
Cheryl A Chessick
, Michael H Allen
, et al.
·
Cochrane Database of Systematic Reviews
·
177
A Meta-analytic Review of the Efficacy of Drug Treatment in Generalized Anxiety Disorder
2005
·
Kristin Mitte
, Peter Noack
, et al.
·
Journal of Clinical Psychopharmacology
·
157
5-HT1A receptor responsivity in anxiety disorders and depression
1991
·
Klaus-Peter Lesch
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
137
Pharmacological treatment of generalized anxiety disorder
2011
·
Jennifer A Reinhold
, Laura A Mandos
, et al.
·
Expert Opinion on Pharmacotherapy
·
102
Neurochemistry and Neurophysiology of Buspirone and Gepirone: Interactions at Presynaptic and Postsynaptic 5-HT1A Receptors
1990
·
FRANK D. YOCCA
·
Journal of Clinical Psychopharmacology
·
101
Neuroendocrine Effects of Azapirones
1990
·
PHILIP J. COWEN
, IAN M. ANDERSON
, et al.
·
Journal of Clinical Psychopharmacology
·
101
Serotonergic mechanisms in anxiety
1994
·
Arlene S. Eison
, Michael S. Eison
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
87
Buspirone: Back to the Future
2015
·
Robert H. Howland
·
Journal of Psychosocial Nursing and Mental Health Services
·
75
Development and Scale-Up of Three Consecutive Continuous Reactions for Production of 6-Hydroxybuspirone
2008
·
Thomas L. LaPorte
, Mourad Hamedi
, et al.
·
Organic Process Research & Development
·
73
Buspirone: An Updated Review of its Clinical Pharmacology and Therapeutic Applications
1997
·
Bret Fulton
, Rex N. Brogden
·
CNS Drugs
·
72
Serotonin: A Common Neurobiologic Substrate in Anxiety and Depression
1990
·
MICHAEL S. EISON
·
Journal of Clinical Psychopharmacology
·
71
Pharmacological and psychological interventions for generalized anxiety disorder in adults: A network meta-analysis
2019
·
Ting-Ren Chen
, Hui-Chuan Huang
, et al.
·
Journal of Psychiatric Research
·
70
Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease
2011
·
Zafar A Usmani
, Kristin V Carson
, et al.
·
Cochrane Database of Systematic Reviews
·
70
PDF
Buspirone in clinical practice.
1990
·
K Rickels
·
PubMed
·
68
Efficacy of Buspirone in the Treatment of Posttraumatic Stress Disorder: An Open Trial
1994
·
James Duffy
, Paul Malloy
·
Annals of Clinical Psychiatry
·
66
Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms
2017
·
Xuefei Huang
, Jing Yang
, et al.
·
Oncotarget
·
63
Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPγS binding
2005
·
Yuji Odagaki
, Ryoichi Toyoshima
, et al.
·
Journal of Psychopharmacology
·
62
Anxiety and Alcoholism: A Serotonin Link
1991
·
Gary D. Tollefson
·
The British Journal of Psychiatry
·
58
Serotonin: a common neurobiologic substrate in anxiety and depression.
1990
·
M S Eison
·
Journal of Clinical Psychopharmacology
·
58
Show more works
View as search
Works count:
172
Citation count:
5,492
Year
Topic
Type